NeoStem says no new securities issued in previous filing NeoStem is clarifying that it is not engaged in a new financing. The registration statement filed earlier is a renewal of an outstanding registration statement covering the issuance of shares underlying warrants that were issued in 2011 and 2012 and remain outstanding. The underlying shares were previously registered, but the registration statement is expiring under SEC rules and needs to be refreshed. No new securities are being offered by NeoStem.
BioLife Solutions biopreservation products used at Progenitor Cell Therapy BioLife Solutions (BLFS) provided an update on use of the company's HypoThermosol storage/shipping media and CryoStor cryopreservation freeze media by Progenitor Cell Therapy, or PCT, a wholly owned subsidiary of NeoStem (NBS) a leader in the emerging cellular therapy field.